you are here: HomeNewsGland pharma
gland pharma
Jump to
44 Results Found
  • 3-Point Analysis | Gland Pharma: What should investors do with stock now? Nov 23, 2020 01:53 PM IST

    3-Point Analysis | Gland Pharma: What should investors do with stock now?

    Gland Pharma's IPO subscription response was tepid compared to the recent entrants. However, it closed 21 percent higher than the issue price of Rs 1500. Let's find out what should investors do post the listing

  • Gland Pharma: Post IPO listing, what should investors do? Nov 23, 2020 09:42 AM IST

    Gland Pharma: Post IPO listing, what should investors do?

    A vertically-integrated model and a strong regulatory compliance history with focus on R&D are tailwinds for Gland Pharma

  • Gland Pharma shares rally 21%, close at Rs 1,820 on listing day Nov 20, 2020 06:08 PM IST

    Gland Pharma shares rally 21%, close at Rs 1,820 on listing day

    Gland Pharma traded with volume of 7,87,955 equity shares on the BSE and 1,13,10,647 shares on the NSE. The market capitalisation stood at Rs 29,725 crore.

  • Gland Pharma climbs 23% on listing day, should investors hold or book profits? Nov 20, 2020 01:21 PM IST

    Gland Pharma climbs 23% on listing day, should investors hold or book profits?

    Experts have a positive long-term view on the stock, given the company's strong financials and hold in the injectable business.

  • Gland Pharma shares debut at Rs 1,710, a 14% premium over issue price Nov 20, 2020 10:00 AM IST

    Gland Pharma shares debut at Rs 1,710, a 14% premium over issue price

    Fosun Singapore and Shanghai Fosun Pharma are the promoters of the company. Their shareholding reduced to 58 percent in the company from 74 percent post issue.

  • Gland Pharma to debut today: Here's what to expect from the listing Nov 19, 2020 04:08 PM IST

    Gland Pharma to debut today: Here's what to expect from the listing

    Gland Pharma has a track record of growth and profitability from a diversified revenue base with healthy cash flows. Also, fundamentals of the company look strong, said Astha Jain of Hem Securities.

  • Gland Pharma IPO: Share allotment finalised, here's how to check Nov 18, 2020 07:18 AM IST

    Gland Pharma IPO: Share allotment finalised, here's how to check

    Now the company is expected to list its equity shares on bourses on November 20

  • Gland Pharma premium rises significantly in grey market ahead of listing Nov 17, 2020 02:00 PM IST

    Gland Pharma premium rises significantly in grey market ahead of listing

    In fact the premium has consistently been falling since the announcement of price band for its IPO in first week of November.

  • Gland Pharma IPO allotment status to be finalised soon: Here is how to check Nov 17, 2020 11:40 AM IST

    Gland Pharma IPO allotment status to be finalised soon: Here is how to check

    After the finalisation of basis of allotment, the unblocking of funds from ASBA account will take place around November 18, and shares will get credited to eligible investors around November 19.

  • Gland Pharma IPO final day: Issue subscribed 2 times, QIB portion booked over 6 times Nov 11, 2020 10:56 AM IST

    Gland Pharma IPO final day: Issue subscribed 2 times, QIB portion booked over 6 times

    On the financial front too, it is sitting with good cash levels with negligible debt levels, a good CAGR growth rate in terms of Revenue & PAT and enjoys sound margins, said Manali Bhatia of Rudra Shares

  • Subscribe to Gland Pharma: Geojit Nov 10, 2020 12:52 PM IST

    Subscribe to Gland Pharma: Geojit

    Geojit has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 07, 2020

  • Subscribe to Gland Pharma: Nirmal Bang Nov 10, 2020 12:44 PM IST

    Subscribe to Gland Pharma: Nirmal Bang

    Nirmal Bang has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 2020

  • Subscribe to Gland Pharma: KR Choksey Nov 10, 2020 12:35 PM IST

    Subscribe to Gland Pharma: KR Choksey

    KR Choksey has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 2020

  • Subscribe to Gland Pharma: Hem Securities Nov 10, 2020 12:24 PM IST

    Subscribe to Gland Pharma: Hem Securities

    Hem Securities has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 2020

  • Gland Pharma IPO subscribed 21% on 2nd day of bidding, retail portion 14% Nov 10, 2020 12:13 PM IST

    Gland Pharma IPO subscribed 21% on 2nd day of bidding, retail portion 14%

    Gland has one of the strongest pipelines in high entry barrier injectables segment, said the brokerage.

  • Subscribe to Gland Pharma: ICICI Direct Nov 10, 2020 08:23 AM IST

    Subscribe to Gland Pharma: ICICI Direct

    ICICI Direct has come out with its report on Gland Pharma. The research firm has recommended to ''Subscribe'' the ipo in its research report as on November 09, 2020

  • 3-Point Analysis | Gland Pharma IPO: Strong play on global generic injectables; should investors subscribe? Nov 09, 2020 12:55 PM IST

    3-Point Analysis | Gland Pharma IPO: Strong play on global generic injectables; should investors subscribe?

    Gland Pharma IPO comes at a time when global pharma industry is in a sweet spot. Should you subscribe? Let’s find out in this edition of 3-Point Analysis.

  • Gland Pharma IPO day 1: Issue subscribed 4.5%, retail portion booked 7.7% Nov 09, 2020 11:10 AM IST

    Gland Pharma IPO day 1: Issue subscribed 4.5%, retail portion booked 7.7%

    The Rs 6,480-crore IPO of Gland Pharma consists a fresh issue of Rs 1,250 crore and an offer for sale of over 3.48 crore equity shares by promoters and selling shareholders

  • Gland Pharma IPO: Much more than a Heparin play; subscribe Nov 09, 2020 10:00 AM IST

    Gland Pharma IPO: Much more than a Heparin play; subscribe

    Gland Pharma's IPO provides an opportunity to take exposure to a steady earnings compounder with strong credentials

  • Gland Pharma opens for subscription today: Should you subscribe? Nov 09, 2020 07:46 AM IST

    Gland Pharma opens for subscription today: Should you subscribe?

    The shareholding of promoters - Fosun Singapore and Shanghai Fosun Pharma - in the company will be reduced to around 58 percent from 74 percent now.

  • Here's why Gland Pharma IPO premium fell significantly in grey market Nov 08, 2020 10:23 AM IST

    Here's why Gland Pharma IPO premium fell significantly in grey market

    Gland Pharma aims to raise Rs 6,479.54 crore via public issue, of which Rs 1,943.86 crore has already been raised from anchor investors on November 6.

  • Gland Pharma IPO: 10 key things you should know before subscribing Nov 07, 2020 03:03 PM IST

    Gland Pharma IPO: 10 key things you should know before subscribing

    The issue will close on November 11 and equity shares are expected to list on the BSE and National Stock Exchange of India on November 20.

  • Gland Pharma garners Rs 1,944 crore from anchor investors ahead of IPO Nov 07, 2020 01:05 PM IST

    Gland Pharma garners Rs 1,944 crore from anchor investors ahead of IPO

    The IPO Committee of the board of directors of the company vide resolution on November 6, 2020 and the selling shareholders in consultation with the book running lead managers to the IPO have "finalised allocation of 1,29,59,089 equity shares in aggregate, to anchor investors at the anchor investor allocation price of Rs 1,500 per equity share", the company informed the BSE.

  • Gland Pharma sets IPO price band at Rs 1,490-1,500, subscription begins November 9 Nov 04, 2020 11:48 AM IST

    Gland Pharma sets IPO price band at Rs 1,490-1,500, subscription begins November 9

    The IPO consists of a fresh issue of Rs 1,250 crore and an offer for sale of 3,48,63,635 equity shares by promoter and other selling shareholders.

  • Chinese parent-owned Gland Pharma's IPO likely to open next week Nov 03, 2020 10:24 PM IST

    Chinese parent-owned Gland Pharma's IPO likely to open next week

    Last month, Gland Pharma received approval from capital markets regulator Sebi to launch an initial public offer which included a fresh issue of Rs 1,250 crore.

Sections